Terms: = Leukemia AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Clinical Outcome
3 results:
1. Epigenomic profiling of glucocorticoid responses identifies cis-regulatory disruptions impacting steroid resistance in childhood acute lymphoblastic leukemia.
Bergeron BP; Diedrich JD; Zhang Y; Barnett KR; Dong Q; Ferguson DC; Autry RJ; Yang W; Hansen BS; Smith C; Crews KR; Fan Y; Pui CH; Pruett-Miller SM; Relling MV; Yang JJ; Li C; Evans WE; Savic D
Leukemia; 2022 Oct; 36(10):2374-2383. PubMed ID: 36028659
[TBL] [Abstract] [Full Text] [Related]
2. The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia.
McElligott AM; Maginn EN; Greene LM; McGuckin S; Hayat A; Browne PV; Butini S; Campiani G; Catherwood MA; Vandenberghe E; Williams DC; Zisterer DM; Lawler M
Cancer Res; 2009 Nov; 69(21):8366-75. PubMed ID: 19826055
[TBL] [Abstract] [Full Text] [Related]
3. [Treatment outcome of multidrug resistance related mRNA expression and c-jun-N-terminal kinase activity in patients with acute myeloid leukemia].
Do JH; Oh SH; Song EJ; Chung JS; Kang CD; Lee EY
Korean J Lab Med; 2007 Aug; 27(4):229-36. PubMed ID: 18094581
[TBL] [Abstract] [Full Text] [Related]
